Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.
- 1998-01-01
- Clinical Trial · n = 85
- Current medical research and opinion 14(3)
- J Breza
- O Dzurny
- A Borowka
- T Hanus
- R Petrik
- G Blane
- H Chadha-Boreham
- PubMed: 9787978
- DOI: 10.1185/03007999809113352
- High evidence
- Clinical
Nocturnal frequency was reduced by 32% and the mean reduction was again highly statistically significant.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 50 mg twice daily